R M Freidinger - JoVE Visualize

Showing results (11-20 of 40) with videos related to

Pageof 4

Sort By:

Molecular Pharmacology|June 1, 1989

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligandR S Chang, T B Chen, M G Bock, et al.

Life Sciences|January 1, 1992

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989

Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.

Journal of Medicinal Chemistry|January 1, 1988

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.

Biochemistry|March 19, 2003

HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAbG B McGaughey, M Citron, R C Danzeisen, et al.

Bioorganic & Medicinal Chemistry Letters|July 19, 2001

Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.

Molecular Pharmacology|January 1, 1986

Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding siteM A Cascieri, G G Chicchi, R M Freidinger, et al.

Journal of Medicinal Chemistry|October 1, 1988

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.

Journal of Medicinal Chemistry|November 16, 2001

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.

Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:

Pageof 4

Molecular Pharmacology|June 1, 1989

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligandR S Chang, T B Chen, M G Bock, et al.

Life Sciences|January 1, 1992

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989

Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogsV M Garsky, P K Lumma, R M Freidinger, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.

Journal of Medicinal Chemistry|January 1, 1988

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.

Biochemistry|March 19, 2003

HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAbG B McGaughey, M Citron, R C Danzeisen, et al.

Bioorganic & Medicinal Chemistry Letters|July 19, 2001

Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.

Molecular Pharmacology|January 1, 1986

Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding siteM A Cascieri, G G Chicchi, R M Freidinger, et al.

Journal of Medicinal Chemistry|October 1, 1988

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.

Journal of Medicinal Chemistry|November 16, 2001

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.

Pageof 4